The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 185.00
Bid: 180.00
Ask: 190.00
Change: 2.50 (1.37%)
Spread: 10.00 (5.556%)
Open: 182.50
High: 185.00
Low: 182.50
Prev. Close: 182.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Jun 2022 07:00

RNS Number : 7089O
Synectics PLC
14 June 2022
 

 

 

RNS

 

14 June 2022

 

 

Synectics plc

("Synectics", the "Company" or the "Group")

 

Trading Update

 

Synectics plc (AIM: SNX), a leader in the design, integration and support of advanced security and surveillance systems, provides the following trading update for the six months ended 31 May 2022 ("H1 2022").

Activity levels in the major end-user markets that Synectics serves generally continue to gather momentum, particularly in Oil & Gas and in US gaming. That recovery is as yet less evident in casinos and gaming resorts in Asia-Pacific where leisure travel has remained subdued. Although there are signs of increased customer activity in this region, firm business remains patchy and difficult to predict.

Trading in H1 2022 was in line with the Board's expectations and produced a considerable positive turnaround from the same period last year, with operating profits expected to be at a broadly similar level to the seasonally stronger second half of last year.

Operating profit for H1 2022 is estimated to be approximately £0.4 million (H1 2021: operating loss £(0.8) million) on revenues of approximately £23.0 million (H1 2021: £22.0 million). Net cash as at 31 May 2022 was approximately £3.9 million (31 May 2021: £3.5 million).

The improved results were largely driven by revenue growth of approximately 20 per cent in the Company's core Systems division as markets severely affected by the pandemic began their recovery. Although the division experienced some disruption to its supply chains from the prevalent global issues, proactive management meant that there was no material impact on delivery schedules or margins. The Systems division's gross margins in H1 2022 held up strongly, reflecting both its ability to pass on cost increases, and further progress in the Group's strategy of increased software content in its deliveries.

Good progress was made in H1 2022 on the Group's large projects for advanced infrastructure surveillance, including Deutsche Bahn in Berlin and the Cloud-based deployment of Synergy for the City of London Corporation and City of London Police. These continue to act as important reference sites for Synectics' core advanced technology.

In H1 2022, Synectics Security, the Group's UK-focused integration division, experienced a decline in revenues compared to the same period last year due principally to customer-led delays on several major projects that had been expected to be largely completed in the half. However, an improvement in the mix of business resulted in higher gross margins and an operating profit in H1 2022 expected to be at a similar level to the satisfactory result achieved in the same period last year.

Overall, the Board is pleased with Synectics' performance in H1 2022 and continues to expect further acceleration in the trajectory of improvement in the second half of the financial year.

Synectics will provide a further update on trading and announce its unaudited interim results for the six months ended 31 May 2022 on 12 July 2022.

 

Paul Webb, Chief Executive of Synectics, commented: "A strong team performance has meant we have been able to deliver our goals for this period despite increasing challenges in the supply chain and with markets still subdued. We have all been working through our 'return to work' challenges, and are in good shape now to push on together and deliver further improved results in the second half of this financial year and beyond"

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief ExecutiveDavid Bedford, Finance Director

email: info@synecticsplc.com

www.synecticsplc.com

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / David Coaten

 

 Ends

 

About Synectics plc

Synectics (AIM: SNX) is a leader in the design, integration and support of advanced security and surveillance systems that enable clients around the world to protect their people, communities, and assets.

Founded over 30 years ago, Synectics has deep industry experience across gaming, energy, urban transport, public space and critical infrastructure projects. The Group's expert engineering teams work in partnership with customers to create integrated product and technology solutions, proven in the most complex and demanding operating environments.

Find out more at www.synecticsplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGMVVFKGZZM
Date   Source Headline
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results
8th Mar 20077:00 amRNSHolding(s) in Company
20th Feb 200712:33 pmRNSGrant of Options
7th Feb 20077:02 amRNSNorth American Contract Wins
7th Feb 20077:02 amRNSInterim Results
6th Feb 200710:14 amRNSDirector/PDMR Shareholding
5th Feb 20077:00 amRNSDirectorate Change
29th Jan 20072:58 pmRNSNotice of Results
26th Jan 20077:01 amRNSTrading Update
28th Dec 20064:36 pmRNSGrant of Options
22nd Dec 20069:37 amRNSTotal Voting Rights & Capital
5th Dec 20067:01 amRNSInterim Results
29th Nov 20063:25 pmRNSDirector/PDMR Shareholding
24th Nov 200611:53 amRNSNotice of Results
24th Oct 20067:01 amRNSAcquisition
4th Oct 20067:00 amRNSTrading Statement
18th Sep 20069:11 amRNSDirectorate Change
13th Jul 20067:01 amRNSIssue of Equity
20th Jun 200610:39 amRNSGrant of Options
14th Jun 20065:06 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.